No significant difference seen in composite adverse neonatal outcome for patients receiving metformin or placebo in addition to insulin

Medical and surgical management of pituitary apoplexy yield similar three-month outcomes

Intensive behavioral interventions recommended for children and teens aged older than 6 years with high BMI

GLP-1 receptor agonists linked to reduced risk for CRC compared with other antidiabetics, including insulin and metformin

Mixed-meal-stimulated mean C-peptide levels at 48 weeks higher for those treated with baricitinib versus placebo

Additionally, among women with diabetes, earlier age at menarche tied to increased stroke risk

Reduction in urine albumin-to-creatinine ratio mediated 84 and 37 percent of the treatment effect on kidney and cardiovascular outcomes

Similarly, very low diastolic BP increases cardiovascular mortality risk with diabetes

Voice analysis may be effective for screening or monitoring of diabetes

Twins randomly assigned to healthy vegan diet have significant decreases in LDL cholesterol concentration, fasting insulin, body weight